Mechanisms of Apoptin-induced cell death

Medical Oncology

Volumn 29, Issue 4, 2012, Pages 2985-2991

  Zhou, Suna ^a   Zhang, Mingxin ^a   Zhang, Jia ^a   Shen, Hui ^a   Tangsakar, Ermek ^a   Wang, Jiansheng ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Apoptin; Apoptosis; Mechanisms; Selectively

Indexed keywords

APOPTIN; CASPASE 8; CERAMIDE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; HIP INTERACTING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; KARYOPHERIN; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 10; PROTEIN KINASE C; PROTEIN P73; SMALL INTERFERING RNA; SPHINGOMYELIN; THREONINE; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DEATH; CELLULAR DISTRIBUTION; HUMAN; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; APOPTOSIS; CAPSID PROTEINS; CHICKEN ANEMIA VIRUS; MOLECULAR SEQUENCE DATA; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SPHINGOMYELINS;

EID: 84867949497     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0119-2     Document Type: Review

References (58)

1. Noteborn MH, Todd D, Verschueren CA, de Gauw HW, Curran WL, et al. A single chicken anemia virus protein induces apoptosis. J Virol. 1994;68(1):346-51.
2. Maddika S, Mendoza FJ, Hauff K, Zamzow CR, Paranjothy T, et al. Cancer-selective therapy of the future: apoptin and its mechanism of action. Cancer Biol Ther. 2006;5(1):10-9.
3. Noteborn MH. Chicken anemia virus induced apoptosis: underlying molecular mechanisms. Vet Microbiol. 2004;98(2):89-94.
4. Backendorf C, Visser AE, de Boer AG, Zimmerman R, Visser M, et al. Apoptin: therapeutic potential of an early sensor of carcinogenic transformation. Annu Rev Pharmacol Toxicol. 2008;48:143-69.
5. Li X, Jin N, Mi Z, Lian H, Sun L, et al. Antitumor effects of a recombinant fowlpox virus expressing Apoptin in vivo and in vitro. Int J Cancer. 2006;119(12):2948-57.
6. Lian H, Jin N, Li X, Mi Z, Zhang J, et al. Induction of an effective anti-tumor immune response and tumor regression by combined administration of IL-18 and Apoptin. Cancer Immunol Immunother. 2007;56(2):181-92.
7. Tavassoli M, Guelen L, Luxon BA, Gäken J. Apoptin: specific killer of tumor cells? Apoptosis. 2005;10(4):717-24.
8. Olijslagers SJ, Zhang YH, Backendorf C, Noteborn MH. Additive cytotoxic effect of Apoptin and chemotherapeutic agents paclitaxel and etoposide on human tumour cells. Basic Clin Pharmacol Toxicol. 2007;100(2):127-31.
9. Pan Y, Fang L, Fan H, Luo R, Zhao Q, et al. Antitumor effects of a recombinant pseudotype baculovirus expressing Apoptin in vitro and in vivo. Int J Cancer. 2010;126(11):2741-51.
10. Jin JL, Gong J, Yin TJ, Lu YJ, Xia JJ, et al. PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in vitro and in vivo. Eur J Pharmacol. 2011;654(1):17-25.
11. Olijslagers S, Dege AY, Dinsart C, Voorhoeve M, Rommelaere J, et al. Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin. Cancer Gene Ther. 2001;8(12):958-65.
12. Yu CM, Xu HT, Du J. Recombinant Apoptin gene retrovirus induces apoptosis in human breast cancer cells 435. Chin J Cancer Res. 2009;21(3):194-201.
13. Li X, Liu Y, Wen Z, Li C, Lu H, et al. Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing Apoptin in vitro and in vivo. Mol Cancer. 2010;9:10.
14. Noteborn MH, de Boer GF, van Roozelaar DJ, Karreman C, Kranenburg O, et al. Characterization of cloned chicken anemia virus DNA that contains all elements for the infectious replication cycle. J Virol. 1991;65(6):3131-9.
15. Danen-Van Oorschot AA, Zhang YH, Leliveld SR, Rohn JL, Seelen MC, et al. Importance of nuclear localization of apoptin for tumor-specific induction of apoptosis. J Biol Chem. 2003;278(30):27729-36.
16. Kuusisto HV, Wagstaff KM, Alvisi G, Jans DA. The C-terminus of Apoptin represents a unique tumor cell-enhanced nuclear targeting module. Int J Cancer. 2008;123(12):2965-9.
17. Wang QM, Fan GC, Chen JZ, Chen HP, He FC. A putative NES mediates cytoplasmic localization of Apoptin in normal cells. Acta Biochim Biophys Sin (Shanghai). 2004;36(12):817-23.
18. Wadia JS, Wagner MV, Ezhevsky SA, Dowdy SF. Apoptin/VP3 contains a concentration-dependent nuclear localization signal (NLS), not a tumorigenic selective NLS. J Virol. 2004;78(11):6077-8.
19. Poon IK, Oro C, Dias MM, Zhang J, Jans DA. Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells. Cancer Res. 2005;65(16):7059-64.
20. Heckl S, Regenbogen M, Sturzu A, Gharabaghi A, Feil G, et al. Value of apoptin's 40-amino-acid C-terminal fragment for the differentiation between human tumor and non-tumor cells. Apoptosis. 2008;13(4):495-508.
21. Rohn JL, Zhang YH, Aalbers RI, Otto N, Den Hertog J, et al. A tumor-specific kinase activity regulates the viral death protein Apoptin. J Biol Chem. 2002;277(52):50820-7.
22. Lee YH, Cheng CM, Chang YF, Wang TY, Yuo CY. Apoptin T108 phosphorylation is not required for its tumor-specific nuclear localization but partially affects its apoptotic activity. Biochem Biophys Res Commun. 2007;354(2):391-5.
23. Heilman DW, Teodoro JG, Green MR. Apoptin nucleocytoplasmic shuttling is required for cell type-specific localization, apoptosis, and recruitment of the anaphase-promoting complex/cyclosome to PML bodies. J Virol. 2006;80(15):7535-45.
24. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 1993;74(6):957-67.
25. Warters RL. Radiation-induced apoptosis in a murine T-cell hybridoma. Cancer Res. 1992;52(4):883-90.
26. Zhuang SM, Shvarts A, van Ormondt H, Jochemsen AG, van der Eb AJ, et al. Apoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cells. Cancer Res. 1995;55(3):486-9.
27. Reed JC. Double identity for proteins of the Bcl-2 family. Nature. 1997;387(6635):773-6.
28. Danen-Van Oorschot AA, Zhang Y, Erkeland SJ, Fischer DF, van der Eb AJ, et al. The effect of Bcl-2 on Apoptin in 'normal' vs transformed human cells. Leukemia. 1999;13(Suppl 1):S75-7.
29. Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science. 1997;278(5345):1966-8.
30. Schoop RA, Kooistra K, Baatenburg De Jong RJ, Noteborn MH. Bcl-xL inhibits p53- but not Apoptin-induced apoptosis in head and neck squamous cell carcinoma cell line. Int J Cancer. 2004;109(1):38-42.
31. Danen-van Oorschot AA, van Der Eb AJ, Noteborn MH. The chicken anemia virus-derived protein Apoptin requires activation of caspases for induction of apoptosis in human tumor cells. J Virol. 2000;74(15):7072-8.
32. Pietersen AM, Rutjes SA, van Tongeren J, Vogels R, Wesseling JG, et al. The tumor-selective viral protein Apoptin effectively kills human biliary tract cancer cells. J Mol Med (Berl). 2004;82(1):56-63.
33. Schoop RA, Verdegaal EM, Baatenburg de Jong RJ, Noteborn MH. Apoptin enhances radiation-induced cell death in poorly responding head and neck squamous cell carcinoma cells. Basic Clin Pharmacol Toxicol. 2010;106(2):130-4.
34. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296(5573):1655-7.
35. Maddika S, Bay GH, Kroczak TJ, Ande SR, Maddika S, et al. Akt is transferred to the nucleus of cells treated with Apoptin, and it participates in Apoptin-induced cell death. Cell Prolif. 2007;40(6):835-48.
36. Jänicke RU, Sohn D, Essmann F, Schulze-Osthoff K. The multiple battles fought by anti-apoptotic p21. Cell Cycle. 2007;6(4):407-13.
37. Maddika S, Panigrahi S, Wiechec E, Wesselborg S, Fischer U, et al. Unscheduled Akt-triggered activation of cyclin-dependent kinase 2 as a key effector mechanism of Apoptin's anticancer toxicity. Mol Cell Biol. 2009;29(5):1235-48.
38. Liu X, Zeidan YH, Elojeimy S, Holman DH, El-Zawahry AM, et al. Involvement of sphingolipids in Apoptin-induced cell killing. Mol Ther. 2006;14(5):627-36.
39. Liu X, Elojeimy S, El-Zawahry AM, Holman DH, Bielawska A, et al. Modulation of ceramide metabolism enhances viral protein Apoptin's cytotoxicity in prostate cancer. Mol Ther. 2006;14(5):637-46.
40. Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004;4(8):604-16.
41. Charruyer A, Grazide S, Bezombes C, Müller S, Laurent G, et al. UV-C light induces raft-associated acid sphingomyelinase and JNK activation and translocation independently on a nuclear signal. J Biol Chem. 2005;280(19):19196-204.
42. Loidl A, Claus R, Ingolic E, Deigner HP, Hermetter A. Role of ceramide in activation of stress-associated MAP kinases by minimally modified LDL in vascular smooth muscle cells. Biochim Biophys Acta. 2004;1690(2):150-8.
43. Maddika S, Booy EP, Johar D, Gibson SB, Ghavami S, et al. Cancer-specific toxicity of Apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. J Cell Sci. 2005;118(Pt 19):4485-93.
44. Marsden VS, Strasser A. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol. 2003;21:71-105.
45. Leliveld SR, Zhang YH, Rohn JL, Noteborn MH, Abrahams JP. Apoptin induces tumor-specific apoptosis as a globular multimer. J Biol Chem. 2003;278(11):9042-51.
46. Leliveld SR, Dame RT, Rohn JL, Noteborn MH, Abrahams JP. Apoptin's functional N- and C-termini independently bind DNA. FEBS Lett. 2004;557(1-3):155-8.
47. Danen-van Oorschot AA, Voskamp P, Seelen MC, van Miltenburg MH, Bolk MW, et al. Human death effector domain-associated factor interacts with the viral apoptosis agonist Apoptin and exerts tumor-preferential cell killing. Cell Death Differ. 2004;11(5):564-73.
48. Teodoro JG, Heilman DW, Parker AE, Green MR. The viral protein Apoptin associates with the anaphase-promoting complex to induce G2/M arrest and apoptosis in the absence of p53. Genes Dev. 2004;18(16):1952-7.
49. Huo DH, Yi LN, Yang J. Interaction with Ppil3 leads to the cytoplasmic localization of Apoptin in tumor cells. Biochem Biophys Res Commun. 2008;372(1):14-8.
50. Maddika S, Wiechec E, Ande SR, Poon IK, Fischer U, et al. Interaction with PI3-kinase contributes to the cytotoxic activity of Apoptin. Oncogene. 2008;27(21):3060-5.
51. Chen K, Luo Z, Tang J, Zheng SJ. A critical role of heat shock cognate protein 70 in Apoptin-induced phosphorylation of Akt. Biochem Biophys Res Commun. 2011;409(2):200-4.
52. Daugaard M, Rohde M, Jäättelä M. The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions. FEBS Lett. 2007;581(19):3702-10.
53. Sun GJ, Tong X, Dong Y, Mei ZZ, Sun ZX. Identification of a protein interacting with Apoptin from human leucocyte cDNA library by using yeast two-hybrid screening. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2002;34(3):369-72.
54. Cheng CM, Huang SP, Chang YF, Chung WY, Yuo CY. The viral death protein Apoptin interacts with Hippi, the protein interactor of Huntingtin-interacting protein 1. Biochem Biophys Res Commun. 2003;305(2):359-64.
55. Guelen L, Paterson H, Gäken J, Meyers M, Farzaneh F, et al. TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells. Oncogene. 2004;23(5):1153-65.
56. Zhong S, Salomoni P, Ronchetti S, Guo A, Ruggero D, et al. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis. J Exp Med. 2000;191(4):631-40.
57. Sun J, Yan Y, Wang XT, Liu XW, Peng DJ, et al. PTD4-apoptin protein therapy inhibits tumor growth in vivo. Int J Cancer. 2009;124(12):2973-81.
58. Jiang J, Cole D, Westwood N, Macpherson L, Farzaneh F, et al. Crucial roles for protein kinase C isoforms in tumor-specific killing by Apoptin. Cancer Res. 2010;70(18):7242-52.